Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Frailty × Protons × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Glioma 2 Glioblastoma 2 Squamous Cell Carcinoma of Head and Neck 1 Resectable Lung Non-Small Cell Carcinoma 1 Radiation Injuries 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Lung Neoplasms 1 Gastroesophageal Junction Adenocarcinoma 1 Frailty 1 Chordoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1 Astrocytoma 1

Interventions

peflavit 1 microcrystalline cellulose 1 fisetin 1 epigallocatechin gallate 1 cabozantinib 1 Temozolomide 1 Quercetin 1 Protons 1 Photons 1 Flavonoids 1 Dasatinib 1 Ascorbic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05548504 2022-09-21

HERAN2

Odense University Hospital

Phase 2 Not yet recruiting

Frailty, Carcinoma, Non-Small-Cell Lung, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon ⚡